The Sixth Annual Men’s Event

For men and all who love them

ANN ARBOR, MI – The Sixth Annual Men’s Event to benefit prostate cancer research and education at the University of Michigan will be held Tuesday, Sept. 25, 2007, at the new Fleming’s Steak House & Wine Bar at 323 North Old Woodward Ave. in Birmingham. Sponsored by The Chrysler Foundation and Fleming’s, this event provides philanthropic support for the U-M Prostate Cancer Research Program.

Since its inception, “The Men’s Event” has raised more than $250,000 to support the battle against prostate cancer. This event brings together a prestigious group of businessmen and women, community leaders, friends and families to enjoy an evening of fabulous food, fine wine and good fellowship while learning more about prostate cancer prevention, detection and treatment.

The ticket price of $500 includes an unlimited bar and hors d’oeuvres, a prime steak dinner and a chance to win extravagant door prizes. A special Prostate Cancer Research Update with U-M urologic oncology physicians will be held during the cocktail hour for individuals interested in learning more about current research and treatment advances.

The dinner’s emcee will be Jim Brandstatter, the voice of University of Michigan and Detroit Lions Football, and will also feature “Big Al” Muskavito of WOMC Oldies 104.3 and Purtan’s People.

John Cueter of Cueter Chrysler Jeep Dodge has donated a two-year/12,000 mile-per-year lease on a 2007 high-end luxury SUV as the grand door prize. The list of live auction items and door prizes includes numerous travel, golf and entertainment items.

“Proceeds generated from The Men’s Event are used to provide seed grants for prostate cancer research. The National Institutes of Health does not support high-risk new research with grant funding until scientific projects are well underway,” says Kenneth J. Pienta, M.D., director of urologic oncology and professor of urology at the U-M Medical School. “Philanthropy provides a tremendous return on investment for our donors and our patients.” Donations from supporters of The Men’s Event are leveraged into larger grants worth 18 times the amount raised each year.

For more information on attending The Men’s Event or general information about prostate cancer research at the University of Michigan, please contact Steffanie Fineman, director of development at the U-M Department of Urology, 734-615-9843 or ssamuels@umich.edu.

Important Prostate Cancer Facts

All men are at risk for prostate cancer. The most common risk factor is age. Your risk is higher if your father or brother had prostate cancer.
Cancer of the prostate is the most common malignancy in American men and the second-leading cause of cancer death, after lung cancer. The American Cancer Society estimates about 234,460 new cases of prostate cancer in the United States this year.
While the death rate for prostate cancer is decreasing and the disease can be detected earlier, more than 27,000 men will die of prostate cancer in 2007.
Prostate cancer research receives half the funding breast cancer receives, yet the disease is twice as prevalent in American men over 60 as breast cancer is in American women.
Receiving a prostate cancer diagnosis raises numerous concerns about how to best treat the disease and how it will impact the future.
Over the past 20 years, the survival rate for prostate cancer has increased from 67 percent to 97 percent.
Being diagnosed with cancer is a life-changing experience for men and their families.
Research at the Universityof Michigan

At U-M, researchers are busy identifying new drugs, new regimens and new treatment approaches to benefit men with prostate cancer and ultimately find a cure. Investigators are focusing research to develop more effective screening tests, identify targets for treatment among the various types of cancer cells, and develop effective drugs.

Private donations have allowed our scientists to advance research novel, innovative research efforts:

Discovery of “gene fusion” - a genetic event likely to cause prostate cancer.
3-D Conformal Therapy - one of the first systems for three-dimensional treatment planning and dose distribution for patients requiring radiation therapy.
Histotripsy - which could potentially allow destruction of the prostate in 10-15 minutes, non-invasively through the skin with ultrasound.
Rapid Autopsy Program - studies how prostate cancer spreads and is one of only two sites worldwide.
Prostate Cancer Survivorship Clinic- patient-centered and focused on quality of life issues.
Contact: Steffanie Fineman, 734-615-9843